Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single-cell RNA-seq analysis of human pancreas from healthy individuals and type 2 diabetes patients

ABSTRACT: Single-cell RNA-seq analysis of human pancreas from healthy individuals and type 2 diabetes patients

PROVIDER: PRJEB15401 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR1630020.fastq.gz	Fastqsanger.gz
	ERR1630030.fastq.gz	Fastqsanger.gz
	ERR1630040.fastq.gz	Fastqsanger.gz
	ERR1630050.fastq.gz	Fastqsanger.gz
	ERR1630060.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 3514

Similar Datasets

Whole-islet RNA-sequencing analysis of human pancreas from healthy individuals and type 2 diabetes patients

Project description:We performed whole-islet RNA-sequencing of human pancreatic islets from healthy and T2D individuals in order to compare the expression data to the corresponding single-cell RNA-sequencing data from the same donors (related single-cell study: Single-cell analysis of human pancreas and T2D, deposited at ArrayExpress under accession E-MTAB-5061: http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-5061/).

2016-09-22 | E-MTAB-5060 | biostudies-arrayexpress

Single-cell RNA-seq analysis of human pancreas from healthy individuals and type 2 diabetes patients

Project description:We used single-cell RNA-sequencing to generate transcriptional profiles of endocrine and exocrine cell types of the human pancreas. Pancreatic tissue and islets were obtained from six healthy and four T2D cadaveric donors. Islets were cultured and dissociated into single-cell suspension. Viable individual cells were distributed via fluorescence-activated cell sorted (FACS) into 384-well plates containing lysis buffer. Single-cell cDNA libraries were generated using the Smart-seq2 protocol. Gene expression was quantified as reads per kilobase transcript and per million mapped reads (RPKM) using rpkmforgenes. Bioinformatics analysis was used to classify cells into cell types without knowledge of cell types or prior purification of cell populations. We revealed subpopulations in endocrine and exocrine cell types, identified genes with interesting correlations to body mass index (BMI) in specific cell types and found transcriptional alterations in T2D. Complementary whole-islet RNA-seq data have also been deposited at ArrayExpress under accession number E-MTAB-5060 (http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-5060).

2016-09-22 | E-MTAB-5061 | biostudies-arrayexpress

Type 2 Diabetes Specific Spatial Differential Gene Expression in Pancreas Visium Data

Project description:Understanding the spatial distribution of gene expression in the pancreas could provide new insights into its function and islet biology. Visium spatial gene expression is a powerful tool for quantifying gene expression of cells within their spatial context. We describe the generation and analysis of spatial transcriptomics data from six pancreas samples from healthy donors. Our analysis revealed high expression of INS within islets. However, we also identified a bleed of highly abundant islet genes (e.g., INS, GCG) into surrounding tissue areas. Through computational analyses, we successfully corrected for this bleed. We then identify genes which are spatially differentially expressed in the Type 2 Diabetes samples. We provide these data for researchers to study the organization of the pancreas and islets.

2024-08-31 | GSE264331 | GEO

Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)

Project description:Type 1 diabetes is an autoimmune disease caused by the destruction of the insulin producing beta cells. We characterized the gene expression profile of pancreatic tissue from four type 1 diabetes patients (Cases 1-4), who died at different stages of the disease (onset and longstanding) by microarray analysis. All samples from patients and controls were obtained after death, at the time of organ donation. Pancreatic blocks from the four diabetic patients and three organ donors (Controls 1-3) were obtained and snap frozen. At the same time, islets from Cases 1 and 4 were isolated from a piece of the pancreas tail by enzymatic digestion (using automated method and handpicking) and snap frozen. Islets from three different organ donors (Controls 4-6) were obtained similarly to those of the diabetic patients. Both pancreatic blocks and islets were stored in liquid nitrogen until the mRNA extraction. For pancreas gene expression profiles, we compared data from three blocks of each of the four type 1 diabetic pancreas with pancreases data from the Controls 1-3. For islets expression profile, we compared data from Cases 1 and 4 islets with islets data from the Controls 4-6. <br><br>

2009-12-01 | E-MEXP-1140 | biostudies-arrayexpress

Gene expression in the pancreas of healthy control, auto-antibody positive, and type 1 diabetic subjects

Project description:These experiments were performed to identify differentially expressed genes in the pancreas of healthy humans, auto-antibody positive and type 1 diabetic patients. All samples were obtained from the network of pancreatic organ donors with diabetes (nPOD). ID numbers are specified. Patient information can be obtained at http://www.jdrfnpod.org/

2015-11-01 | GSE72492 | GEO

microRNA sequencing of plasma exosomes from normal individuals, patients with type 2 diabetes.

Project description:To investigate the differences in microRNA expression in plasma exosomes among normal individuals, patients with type 2 diabetes, we employed Agilent microarray expression profiling as a discovery platform to detect changes in microRNA levels in different target populations.

2025-03-28 | GSE262614 | GEO

Transcriptional profiling by array of microRNAs of human peripheral blood mononuclear cells - PBMC - from control individuals for Type 2 diabetes mellitus patients

Project description:The microRNA oligo microarrays were used to determine expression profiles of peripheral blood mononuclear cells from control healthy individuals and compare to type 2 diabetes mellitus (T2DM) patients, aiming the identification of possible disease related MicroRNAs.

2015-04-01 | E-MTAB-2902 | biostudies-arrayexpress

Circulating microRNAs in young individuals with long-duration type 1 diabetes in comparison with healthy controls

Project description:MicroRNAs (miRNAs) are short non-coding RNAs that are involved in post-transcriptional control of gene expression. The objective of this case-control study was to explore circulating miRNAs in young individuals with long-duration type 1 diabetes (T1D) and healthy controls. Twelve adolescents, age 15.0–17.9 years, with T1D duration of more than 8 years (mean 11.1 years), were enrolled from the Swedish diabetes quality registry. An age-matched control group (n = 12) was recruited. Circulating miRNAs (n = 187) were analyzed by quantitative PCR. We observed that 27 miRNAs were upregulated and one was downregulated in T1D. Six of these miRNAs were tissue-enriched (blood cells, gastrointestinal, nerve, and thyroid tissues). Six miRNAs with the largest difference in plasma, five up-regulated (hsa-miR-101-3p, hsa-miR-135a-5p, hsa-miR-143-3p, hsa-miR-223-3p and hsa-miR-410-3p (novel for T1D)) and one down-regulated (hsa-miR-495-3p), with P-values below 0.01, were selected for further in-silico analyses. AKT1, VEGFA and IGF-1 were identified as common targets. In conclusion, 28 of the investigated miRNAs were differently regulated in long-duration T1D in comparison with controls. Several associations with cancer were found for the six miRNAs with the largest difference in plasma. Circulating miRNAs are potential biomarkers and treatment targets with clinical implications for diabetes-related complications.

2023-10-18 | GSE226755 | GEO

gene expression Fulminant type 1 diabetes vs classical type 1A diabetes vs healthy controls

2014-01-01 | GSE44314 | GEO

gene expression Fulminant type 1 diabetes vs classical type 1A diabetes vs healthy controls

Project description:We determined the genes that were differentially expressed between fulminant type 1 diabetes and classical type 1A diabetes or healthy control using gene expression microarray in peripheral blood cells. Ten patients with type 1 diabetes (5 fulminant and 5 classical type 1A) and 6 healthy controls were enrolled in this study. All patients had recovered from ketosis or ketoacidosis at disease onset and had been receiving intensive insulin injection therapy for at least 1 month, which means that all patients and healthy controls were free of metabolic derangements at the time of blood sampling. To determine the genes that were differentially expressed among fulminant type 1 diabetes, classical type 1A and healthy controls, a volcano plot analysis (fold change >1.5 and p-value <0.05) was performed.

2014-01-01 | E-GEOD-44314 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data